Digenean trematodes are a large, complex group of parasitic flatworms that infect an incredible diversity of organisms, including humans. Larval development of most digeneans takes place within a snail (Gastropoda). Compatibility between snails and digeneans is often very specific, such that suitable snail hosts define the geographical ranges of diseases caused by these worms. The immune cells (hemocytes) of a snail are sentinels that act as a crucial barrier to infection by larval digeneans. Hemocytes coordinate a robust and specific immunological response, participating directly in parasite killing by encapsulating and clearing the infection. Hemocyte proliferation and differentiation are influenced by unknown digeneanspecific exogenous factors. However, we know nothing about the endogenous control of hemocyte development in any gastropod model. Here, we identify and functionally characterize a progranulin [Biomphalaria glabrata granulin (BgGRN)] from the snail B. glabrata, a natural host for the human blood fluke Schistosoma mansoni. Granulins are growth factors that drive proliferation of immune cells in organisms, spanning the animal kingdom. We demonstrate that BgGRN induces proliferation of B. glabrata hemocytes, and specifically drives the production of an adherent hemocyte subset that participates centrally in the anti-digenean defense response. Additionally, we demonstrate that susceptible B. glabrata snails can be made resistant to infection with S. mansoni by first inducing hemocyte proliferation with BgGRN. This marks the functional characterization of an endogenous growth factor of a gastropod mollusc, and provides direct evidence of gain of resistance in a snail-digenean infection model using a defined factor to induce snail resistance to infection.
Biomphalaria glabrata | Schistosoma mansoni | schistosomiasis | granulin | hematopoiesis S nails of the genus Biomphalaria serve as the intermediate host for Schistosoma mansoni, one of the species of parasitic flatworms that cause schistosomiasis. The extensive amplification of the parasite within the snail host complicates disease control efforts and is one of the reasons that schistosomiasis continues to be one of the most important neglected tropical diseases. Studies investigating compatibility between Biomphalaria snails and S. mansoni suggest that the snail immune response plays a crucial role in determining infection outcome. Although circulating humoral factors are known to play an important role in determining infection outcome via recognition of various parasite targets, or by directly damaging the parasite tegument (1) (2) (3) (4) , it is ultimately the immune cells of the snail, known as hemocytes, that are primarily responsible for encapsulating and eliminating the parasite (5) .
The central role of hemocytes in the anti-schistosome response underscores the importance of maintaining suitable numbers of circulating and tissue-resident immune cells. We currently understand very little about the mechanics of hematopoiesis in gastropods. Our limited understanding of the process suggests that the primary hematopoietic organ in snails is a thin tissue located in the anterior of the pericardial region known as the amoebocyteproducing organ (APO) (6) . Following stimulation with excretory/ secretory (ES) products of digenean trematodes, such as S. mansoni (7) or Echinostoma paraensei (8), the APO noticeably swells and displays an increase in mitotic events (9) . The hemocytes generated during these events tend to be adherent and granulocytic, and exhibit greater capacity to generate humoral factors relevant to parasite killing compared with the preexisting population (2) . Following the stimulation of hemocyte development by exogenous factors, the proportion of hemocyte subsets alters to favor the granulocytic morphology (9) that is typically associated with parasite encapsulation (10), phagocytosis (2) , and the production of reactive oxygen and nitrogen intermediates (11) important for parasite killing.
Parasite-specific factors that are excreted or secreted upon initial infection of the snail are important drivers of hematopoiesis in B. glabrata. The second, and lesser-understood, drivers are endogenous snail growth factors that, in response to infection, induce hemocyte proliferation/differentiation within the APO. Recent studies screening the transcriptome and proteome of B. glabrata have yielded promising candidates that possess canonical domains associated with hematopoietic factors of other organisms, both invertebrate and vertebrate (12) .
Granulins are evolutionarily conserved growth factors. Whereas fungi appear to lack a granulin gene (GRN), other members of the plant and animal kingdoms surveyed so far possess at least one copy of GRN. Granulins are identified by a unique 12-cysteine motif that can be found, often repeatedly, throughout the progranulin protein (PGRN). These are secreted propeptides that can be subsequently cleaved into smaller functional units by elastase (13) . Progranulin is involved in numerous biological processes including tissue repair (14) , early embryogenesis, inflammation, Significance Snails serve as hosts for the larval development of many medically and agriculturally important parasitic flatworms, including schistosomes, blood flukes that collectively infect more than 260 million people globally. Here, we functionally characterize a granulin-like snail growth factor that drives the development of snail immune cells, thereby making a schistosome-susceptible snail resistant to infection. This study presents the functional characterization of an endogenous gastropod growth factor as well as demonstrated reversal of a susceptible snail phenotype toward resistance using a defined snail factor. neurobiology, and cell proliferation (15) , via activation of the MAPK pathway (13) . The products of PGRN cleavage (usually ∼6 kDa) can also be functional in a variety of roles that includes participation in and activation of the immune response (16) .
We report on the identification and functional characterization of a progranulin molecule [B. glabrata granulin (BgGRN)] from the snail B. glabrata. This study represents a number of significant advancements for the B. glabrata-S. mansoni infection model and for the field of gastropod immunobiology. We demonstrate that BgGRN expression is responsive to S. mansoni challenge and induces the proliferation of B. glabrata immune cells, driving the in vivo development of an adherent hemocyte subset distinct from resident hemocytes. This effect is initiated via induction of the MAPK signaling pathway, and can be inhibited by knockdown of BgGRN using RNAi as well as via preincubation with a blocking antibody. Administration of recombinant BgGRN into a B. glabrata snail strain that is highly susceptible to S. mansoni infection before challenge resulted in a significant reversal of the susceptible phenotype. This study demonstrates the induction of resistance phenotype following S. mansoni challenge by using a defined gastropod-specific factor.
Results

In Silico Analysis of BgGRN
BgGRN domain prediction and comparison with schistosome granulin. The B. glabrata, Schistosoma mansoni, Schistosoma hematobium, and Schistosoma japonicum progranulin proteins all possess multiple granulin domains ( Fig. 1 A and B and Fig. S1 ). B. glabrata GRN has four predicted granulin domains characterized by amino acid residues 68-112, 158-200, 237-279, and 319-361. Modeling of BgGRN suggests that it shares secondary and tertiary structural properties with known structures of human granulin A and carp granulin. Although the number of granulin domains differ between BgGRN and the human and carp granulins, superimposition reveals predicted overlap of the α-helices and β-sheets associated with the conserved 12-cysteine domains (Fig. 1C) . Signal peptide and cleavage site annotations. BgGRN has a predicted size of ∼44 kDa, and was consistently observed as a single band in Western blot of nonmanipulated snail plasma, as was recombinant BgGRN (rBgGRN). S. mansoni sporocyst ES products were not positive for GRN when probed with anti-BgGRN antibody. BgGRN possesses a predicted secretion signal domain in residues 1-18 ( Fig. 1B) , along with five elastase cleavage sites. Four of these sites immediately follow the four granulin domains, and the fifth cleavage site is predicted at the C-terminal end of pro-BgGRN. Incubation of rBgGRN with porcine elastase supports an elastasemediated mechanism for processing of pro-BgGRN, yielding two distinct ∼18-and ∼8-kDa bands that are consistent with the smaller predicted size of the BgGRN cleavage products (Fig. S2 ). Longer elastase treatment appeared to produce more of the 8-kDa cleavage product at the expense of the larger pro-BgGRN (Fig. S2 ). Although cleavage products at these approximate sizes were not detected by Western blot analysis of plasma isolated from nonmanipulated snails, cleavage products were observed in the plasma of S. mansoni-challenged M-line (only ∼18-kDa product; Fig. 2B , Inset), and BS-90 (∼18-and ∼8-kDa products; Fig. 2A , Inset) and hemocyte lysates (∼18-and ∼8-kDa products; Fig. S3 ).
Analysis of BgGRN Transcript and Protein Expression.
Quantitative RT-PCR analysis of BgGRN transcript at key time points during the intramolluscan development of S. mansoni. The mean basal transcript abundance of BgGRN as measured by specific primed (Table S1 ) reactions in BS-90 strain B. glabrata compared with M-line strain was found to be very similar following normalization to β-actin. The mean ΔCτ BgGRN value in nonmanipulated BS-90 snails was 7.78 (SEM = 0.80; n = 5) compared with 7.46 (SEM = 0.11; n = 5) in M-line snails. No change in BgGRN expression was observed at 1 h post challenge (hpc) with S. mansoni in BS-90 or M-line snails (Fig.  2) ; however, after 1 h, each snail strain displayed different expression profiles. BgGRN transcript abundance increased as early as 3 hpc in BS-90 snails [fold change (Rq) = 9.3, SEM = 4.77], and, by 12 hpc, BgGRN abundance had increased significantly compared with control BS-90 snails (Rq = 26.8, SEM = 5.3). Highest BgGRN transcript levels appeared at 1 d post challenge (dpc; Rq = 38.5, SEM = 7.88), and then decreased consistently from 2 dpc until day 35 (Rq day 2 = 17.5, SEM = 2.01; Rq day 35 = 1.05, SEM = 0.17; Fig. 2A ). Compared with M-line snails challenged at the same time, the BS-90 snail BgGRN transcript levels were significantly higher at 12 h and 1 dpc (P < 0.05). None of the BS-90 snails tested positive for S. mansoni GAPDH after 3 dpc, a result consistent with the BS-90 snails being resistant to infection with S. mansoni and clearing the infection within 4 d (17) .
BgGRN also increased in abundance following challenge of M-line B. glabrata with S. mansoni (Fig. 2B ). Increases were observed at 3 hpc (Rq = 4.3, SEM = 1.26), peaking at 1 dpc (Rq 1 day = 15.58, SEM = 2.25). Although BgGRN transcript levels declined after 1 dpc, relative expression compared with BS-90 snails remained consistently high, with a second peak in expression at day 35 (Rq day 2 = 8.32, SEM = 1.65; Rq day 35 = 11.11, SEM = 2.70). BgGRN transcript abundance was significantly higher than controls at 1 and 35 dpc (P < 0.05). A total of 96% of the experimental M-line snails were positive for S. mansoni GAPDH, indicating successful infections in these snails. Plasma BgGRN lagged behind transcript expression, with peak expression at 2 dpc in BS-90 and M-line snails but with earlier appearance and higher abundance in the former (Fig. 2, Inset) .
Plasma BgGRN in B. glabrata before and after siRNA-mediated knockdown. In both snail strains, injection of BgGRN-specific siRNA oligos (Table S1 ) effectively knocked down BgGRN expression, (Fig. 3) . The mean baseline percentage of BrdU+ circulating hemocytes in BS-90 snails was found to be 17.9% (SEM = 1.4%), compared with 19.8% (SEM = 1.3%), 28% (SEM = 1.6%), 34% (SEM = 2.1%), and 40.1% (SEM =
.67 nM) increased as a result of S. mansoni challenge in BS-90 snails to a peak of 110.3 ± 16.3 nM at day 2 post challenge. Circulating BgGRN returned to baseline concentrations (13.4 ± 3.76 nM) by day 8 post challenge (Fig. S5) . The percentage of cells that had incorporated BrdU following BgGRN injection was comparable to the positive control phorbol 12-myristate 13-acetate (PMA), in which 24% (SEM = 1.2%), 29% (SEM = 1.5%), and 38.3% (SEM = 2.1%) of circulating hemocytes were positive for BrdU after injection of 100, 200, and 300 nM PMA, respectively. Inhibition of the ERK signaling pathway by U0126 at a concentration of 10 μM abrogated BgGRN and PMA-induced proliferation (i.e., BrdU incorporation) in circulating hemocytes (Fig. 3) .
BgGRN elicited very similar results when applied to B. glabrata embryonic (Bge) cells (n = 6 for all treatments) for 48 h under in vitro culture conditions (Fig. S6) and [23.3% (SEM = 1.0%), respectively] compared with controls (as detailed earlier; Fig. 3 and Fig. S6 ). Assessment of newly proliferated hemocytes using B. glabrata fibrinogen-related protein 3 (BgFREP3) (2) and Bg Toll-like receptor (BgTLR) (18)-proteins known to be associated with resistance to S. mansoni-indicates that BgGRNinduced hemocytes have a higher percentage of BgTLR-positive cells whereas the proportion of BgFREP3-positive cells was unaffected (Fig. S7) .
Western blot analysis confirmed that induction of cellular proliferation by BgGRN occurred, in part, via phosphorylation of the p44/42 MAPK in the ERK signaling pathway (Fig. S8) . Injection of 100 nM rBgGRN into BS-90 snails resulted in phosphorylation of ERK1/2 at 15 min post injection, with maximal phosphorylated ERK compared with total ERK observed at 30 and 60 min post induction. At 90, 120, and 240 min post treatment, the amount of phosphorylated ERK declined, but remained detectable. Total ERK levels remained constant. As with other assessments of B. glabrata ERK1/2 analyses by Western blot, only a single band was easily visible in our experiments (19) . . These values reflect 126% and 189% increases in the number of circulating hemocytes in BS-90 and M-line snails, respectively, increasing the number of adherent hemocytes in the M-line snails such that there was no statistically significant difference between the baseline BS-90 and M-line + rBgGRN groups. We confirmed that the increase in adherent hemocytes was the direct result of BgGRNinduced proliferation by enumerating BrdU+ adherent hemocytes following BgGRN injection in snails (Fig. S9) . Preincubation of rBgGRN with a polyclonal αBgGRN antibody blocked the increase in adherent cell numbers, confirming that the proliferative effect was the result of application of rBgGRN (Fig. 4A) .
Knockdown Infection. Significantly fewer M-line snails injected with rBgGRN, before exposure to S. mansoni, developed patent infections compared with snails injected with a recombinant protein control (Fig.  4B ). This trend was observed throughout the course of the intramolluscan infection. The percentages of the experimental snail group (n = 100) that shed S. mansoni cercariae were 0%, 14%, 30%, 34%, and 32% at weeks 4, 5, 6, 7, and 8, respectively. In contrast, 2%, 59%, 80%, 88%, and 84% of the control snails (n = 50) shed cercariae at the same time post challenge. The percentage of infected snails was significantly different between rBgGRN-injected M-line snails and those injected with the recombinant protein control from week 5 post challenge onward (Fig. 4B ). Sporocysts were not found in any of the M-line snails that did not shed cercariae. The knockdown of BgGRN in BS-90 snails had a small impact on S. mansoni challenge outcome: 6%, 10%, and 11% shed S. mansoni cercariae on weeks 6, 7, and 8, respectively (n = 100), whereas none of the GFPknockdown controls shed cercariae at any point (n = 50; Fig. 4B ).
Discussion
Encapsulation of schistosome sporocysts by snail hemocytes is critical for the elimination of the parasite (5, 10) . This highlights the importance of maintaining a sufficient population of readily mobilized hemocytes within a snail at all times, and also the ability to drive production of new cells rapidly in response to challenge. The results of this study demonstrate that BgGRN participates in the hematopoietic events that control the production of the circulating hemocyte population. Introduction of BgGRN into B. glabrata snails that are naturally susceptible to S. mansoni infection resulted in a 54% reduction in the number of snails successfully infected by week 7 post challenge. That sporocysts were not observed upon dissection of these refractory M-line snails implies that the snails had successfully cleared any parasites. Underpinning this impressive change in infection outcome is a significant increase in the generation of circulating adherent hemocytes, which is the hemocyte subset that participates in the encapsulation of S. mansoni sporocysts (10) . Adherent hemocytes are also highly phagocytic (2) and are responsible for the production of reactive and nitrogen intermediates (11) and soluble immune factors that are important for successful clearance of digenetic trematodes (1, 2) . This cell population nearly doubled following administration of rBgGRN.
Whether the snails in this study defended against infection by S. mansoni because they had higher circulating cell numbers, or because those additional cells were immunologically distinct and conveyed new immune functionality, is a central question. To address it, we used two known immunological markers of snail resistance to S. mansoni infection: BgFREP3 (3) and BgTLR (18) . That BgTLR was found to be proportionally higher on BrdU-positive cells induced by BgGRN, and BgFREP3 was not, suggests that the hemocyte population induced by BgGRN may be more geared toward the cellular immune response than the humoral. Increase in the BgGRNinduced adherent hemocyte numbers in the susceptible M-line strain of B. glabrata paralleled the mean number of hemocytes present in the naturally refractory BS-90 strain before stimulation. These findings support the hypothesis that B. glabrata resistance to S. mansoni infection is influenced by the hemocyte numbers and repertoire of the snail (5) .
BgGRN possesses five predicted elastase cleavage sites that are each located immediately following one of the four 12-cysteine granulin domains. Similar to observations that have been made in studies focusing on human PGRN (16) , incubation of rBgGRN with elastase results in the production of ∼8-kDa granulin fragments that would be predicted should all cleavage sites be processed; at least one intermediate product is consistently present in BgGRN elastase digests that resides at ∼18 kDa, similar in size to the ∼15-kDa intermediate fragment observed when human PGRN is digested with elastase (16). As porcine elastase was used to cleave rBgGRN, it is possible that differences between porcine elastase and the elastase of B. glabrata underpin the cleavage patterns observed. B. glabrata elastases were found to possess catalytic sites known to be active in human and porcine elastases (Fig.  S10 ), indicating that they do possess the canonical motifs relevant for traditional elastase function (20) . However, two of the three B. glabrata elastase variants found had only incomplete sequences available, and, consequently, the final catalytic residue could not be compared.
Native BgGRN was detectable in the plasma of unexposed B. glabrata only in its progranulin form; the ∼18-kDa cleavage product was observed only in plasma (of both M-line and BS-90 snails) following S. mansoni challenge, and the ∼8-kDa product was seen only in BS-90 plasma following challenge. In addition, the intermediate ∼18-kDa and smaller ∼8-kDa fragments were observed in the cytoplasmic fractions of B. glabrata hemocyte lysates. These observations suggest that activation or stimulation of the hemocytes (or other BgGRN producing cells) leads to the cleavage of BgGRN. These observations are supported by studies demonstrating that, in some cases, cleavage of PGRN by enzymes such as matrix metalloproteinase-12 occurs within the cytoplasm (21) . Whether the cytoplasmic BgGRN and observed fragments differ functionally from extracellular BgGRN remains unknown. The source of the cytoplasmic BgGRN, which could derive from extracellular BgGRN that enters hemocytes or posttranslational processing of BgGRN before secretion, remains to be determined.
Although the hemocyte receptor mediating the proliferative effects of BgGRN observed in this study is unknown, there are a number of candidate receptors that warrant investigation. Even within the mammalian PGRN literature, there remains uncertainty regarding a definitive GRN receptor. Sortilin (22) and TNF receptors (23) have been implicated in recognition of PGRN, although recent evidence contradicts these initial reports (24) . TLR9 activation has also been found to be reliant on PGRN as a cofactor (25) . At present, we know very little about whether homologs of these molecules exist in B. glabrata. Analysis of the B. glabrata genome highlights the presence of genes that possess high predicted amino acid identity to the canonical domains that characterize TNF receptors and sortilin. However, whether these genes are expressed, or encode for proteins that function in a similar manner to known mammalian molecules, has not yet been investigated to our knowledge. Of the possible candidate molecules that may interact with BgGRN, TLRs are the best characterized in B. glabrata. A number of leucine-rich repeat domain-containing transcripts have been identified in the B. glabrata genome, and at least 13 of these appear to be bona fide TLRs possessing a toll-interleukin-1 domain. Although little is known about the functions of these TLRs, the fact that B. glabrata possesses many of the downstream components associated with TLR signaling in other organisms (26) , and that at least one TLR in B. glabrata is highly abundant on BgGRN-induced adherent hemocytes, is indicative that they likely retain their role as pattern-recognition receptors in B. glabrata and are important participants in the immune response.
Although the receptor for BgGRN may remain unknown, it appears that the effects of BgGRN are mediated by signaling via the MAPK pathway and ERK1/2. The signaling pathway used by PGRN appears to be a highly conserved aspect of its biology (15) . This is noteworthy, as it has been demonstrated that S. mansoni is able to interfere with the phosphorylation of ERK1/2 in susceptible snails, but not those that are phenotypically resistant (19) . The kinetics of ERK1/2 phosphorylation following rBgGRN stimulation of hemocytes has also been observed by using human recombinant PGRN (27) ; however, phosphorylated ERK1/2 is detectable for a longer time (4 h vs. ∼2 h).
The 12-cysteine motif that characterizes granulins defines the protein and confers its conserved secondary and tertiary structure. It may also be responsible for certain functions (28) . Investigations in carp identified three isoforms of carp GRN (29) that were later associated with mononuclear phagocytes (30) . Functional studies of the carp granulin homolog in the goldfish demonstrated that this teleost granulin shares hematopoietic functions with its mammalian counterparts, inducing proliferation of myeloid cells in vitro (31) . Recent studies focusing on a PGRN produced by the flatworm parasite Opisthorchis viverrini demonstrate OvGRN can induce proliferation in fibroblasts of the parasite's human host and fibroblast cell lines, thereby providing a plausible mechanism for the high rates of liver cancer in individuals infected by O. viverrini (32, 33) . The OvGRN studies provide plausibility for a functional role of parasite GRNs on certain host tissues or, alternatively, host GRNs on certain parasite tissues, and highlight the functional and structural conservation of granulins.
The variety of biological functions that PGRN is capable of is impressive, and it is likely that BgGRN may also participate in wound healing, immunological defense, and neuronal development in B. glabrata. Despite its pleiotropic function, we have demonstrated that BgGRN is an important growth factor in B. glabrata, driving hemocyte proliferation and development of an adherent hemocyte subset that is central to the defense of the snail against S. mansoni. Although the list of factors and genes that influence compatibility between B. glabrata and S. mansoni continues to grow, we demonstrate in this study that hematopoietic events regulated by endogenous factors such as granulin can significantly impact the outcome of S. mansoni infection, and that not all hemocytes are equal when considering their role in the immune response.
Materials and Methods
Additional description of materials and methods is provided in SI Materials and Methods.
Snail and Bge Cell Culture and Maintenance. The M-line and BS-90 strains of the snail B. glabrata are susceptible and refractory to infection with S. mansoni, respectively. Both snail populations are maintained in colonies at the University of Alberta as previously described (34) . The Bge cell line (35) (American Type Culture Collection NR-21959) was maintained in Bge cell medium by using established protocols (36) .
Anti-BgGRN Polyclonal Antibody Generation and Validation. A mouse antiBgGRN polyclonal antibody was generated against the recombinant BgGRN (GenScript). The antibody was affinity purified using a Protein G affinity column (no. 17-0404-01; GE Healthcare) and then further purified against recombinant BgGRN. It was effective for Western blot detection of native BgGRN at concentrations of 1:5,000, and was found to block the proliferation-inducing effects of rBgGRN at concentrations of 1:250. All protocols involving animals were carried out in accordance with the Canadian Council on Animal Care Guidelines and Policies with approval from the Animal Care and Use Committee (Biosciences) for the University of Alberta AUP00000057.
